1. Cell Biology

BLOS1 mediates kinesin switch during endosomal recycling of LDL receptor

  1. Chang Zhang
  2. Chanjuan Hao
  3. Guanghou Shui  Is a corresponding author
  4. Wei Li  Is a corresponding author
  1. Capital Medical Universtiy, China
  2. Chinese Academy of Sciences, China
https://doi.org/10.7554/eLife.58069
Share this article
Cite this article
  1. Chang Zhang
  2. Chanjuan Hao
  3. Guanghou Shui
  4. Wei Li
(2020)
BLOS1 mediates kinesin switch during endosomal recycling of LDL receptor
eLife 9:e58069.
https://doi.org/10.7554/eLife.58069
  2. Download BibTeX
  3. Download .RIS

Abstract

Low-density lipoprotein receptor (LDLR) in hepatocytes plays a key role in normal clearance of circulating LDL and in whole body cholesterol homeostasis. The trafficking of LDLR is highly regulated in clathrin-dependent endocytosis, endosomal recycling and lysosomal degradation. Current studies focus on its endocytosis and degradation. However, the detailed molecular and cellular mechanisms underlying its endosomal recycling are largely unknown. We found that BLOS1, a shared subunit of BLOC-1 and BORC, is involved in LDLR endosomal recycling. Loss of BLOS1 leads to less membrane LDLR and impairs LDL clearance from plasma in hepatocyte-specific BLOS1 knockout mice. BLOS1 interacts with kinesin-3 motor KIF13A, and BLOS1 acts as a new adaptor for kinesin-2 motor KIF3 to coordinate kinesin-3 and kinesin-2 during the long-range transport of recycling endosomes (REs) to plasma membrane along microtubule tracks to overcome hurdles at microtubule intersections. This provides new insights into RE's anterograde transport and the pathogenesis of dyslipidemia.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Chang Zhang

    Beijing Children's Hospital, Capital Medical Universtiy, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.

  2. Chanjuan Hao

    Beijing Children's Hospital, Capital Medical Universtiy, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.

  3. Guanghou Shui

    Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China
    For correspondence
    ghshui@genetics.ac.cn
    Competing interests
    The authors declare that no competing interests exist.

  4. Wei Li

    Beijing Children's Hospital, Capital Medical Universtiy, Beijing, China
    For correspondence
    liwei@bch.com.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0248-5510

Funding

Ministry of Science and Technology of the People's Republic of China (2019YFA0802104)

  • Wei Li

National Natural Science Foundation of China (31830054; 91539204)

  • Wei Li

National Natural Science Foundation of China (91954104; 81670789)

  • Chanjuan Hao

Chinese Academy of Sciences (XDA12030211)

  • Guanghou Shui

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Li Yu, Tsinghua University, China

Ethics

Animal experimentation: All animal work was approved by the Institutional Animal Care and Use Committee of the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences (mouse protocol KYD2005-006).

Version history

  1. Received: April 20, 2020
  2. Accepted: November 12, 2020
  3. Accepted Manuscript published: November 12, 2020 (version 1)
  4. Version of Record published: November 25, 2020 (version 2)

Copyright

© 2020, Zhang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,420
    views
  • 302
    downloads
  • 8
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Chang Zhang
  2. Chanjuan Hao
  3. Guanghou Shui
  4. Wei Li
(2020)
BLOS1 mediates kinesin switch during endosomal recycling of LDL receptor
eLife 9:e58069.
https://doi.org/10.7554/eLife.58069

Share this article

https://doi.org/10.7554/eLife.58069

Categories and tags

Research organism

Further reading

    1. Cell Biology

    Novel autophagy inducers by accelerating lysosomal clustering against Parkinson’s disease

    Yuki Date, Yukiko Sasazawa ... Shinji Saiki
    Research Article Updated

    The autophagy-lysosome pathway plays an indispensable role in the protein quality control by degrading abnormal organelles and proteins including α-synuclein (αSyn) associated with the pathogenesis of Parkinson’s disease (PD). However, the activation of this pathway is mainly by targeting lysosomal enzymic activity. Here, we focused on the autophagosome-lysosome fusion process around the microtubule-organizing center (MTOC) regulated by lysosomal positioning. Through high-throughput chemical screening, we identified 6 out of 1200 clinically approved drugs enabling the lysosomes to accumulate around the MTOC with autophagy flux enhancement. We further demonstrated that these compounds induce the lysosomal clustering through a JIP4-TRPML1-dependent mechanism. Among them, the lysosomal-clustering compound albendazole promoted the autophagy-dependent degradation of Triton-X-insoluble, proteasome inhibitor-induced aggregates. In a cellular PD model, albendazole boosted insoluble αSyn degradation. Our results revealed that lysosomal clustering can facilitate the breakdown of protein aggregates, suggesting that lysosome-clustering compounds may offer a promising therapeutic strategy against neurodegenerative diseases characterized by the presence of aggregate-prone proteins.

    1. Cancer Biology
    2. Cell Biology

    CYRI-B-mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake

    Savvas Nikolaou, Amelie Juin ... Laura M Machesky
    Research Article Updated

    Pancreatic ductal adenocarcinoma carries a dismal prognosis, with high rates of metastasis and few treatment options. Hyperactivation of KRAS in almost all tumours drives RAC1 activation, conferring enhanced migratory and proliferative capacity as well as macropinocytosis. Macropinocytosis is well understood as a nutrient scavenging mechanism, but little is known about its functions in trafficking of signalling receptors. We find that CYRI-B is highly expressed in pancreatic tumours in a mouse model of KRAS and p53-driven pancreatic cancer. Deletion of Cyrib (the gene encoding CYRI-B protein) accelerates tumourigenesis, leading to enhanced ERK and JNK-induced proliferation in precancerous lesions, indicating a potential role as a buffer of RAC1 hyperactivation in early stages. However, as disease progresses, loss of CYRI-B inhibits metastasis. CYRI-B depleted tumour cells show reduced chemotactic responses to lysophosphatidic acid, a major driver of tumour spread, due to impaired macropinocytic uptake of the lysophosphatidic acid receptor 1. Overall, we implicate CYRI-B as a mediator of growth and signalling in pancreatic cancer, providing new insights into pathways controlling metastasis.

    1. Cell Biology
    2. Physics of Living Systems

    Cell Migration: Pump up the volume

    Qin Ni, Sean X Sun
    Insight

    An influx of water molecules can help immune cells called neutrophils to move to where they are needed in the body.